Intranasal Corticosteroid Spray for Post-COVID Nasal Congestion
For a 75-year-old man with residual nasal congestion and mild headache after COVID-19, use an intranasal corticosteroid spray such as mometasone furoate, fluticasone propionate, or budesonide. These are the most effective medication class for controlling nasal congestion and rhinorrhea 1.
Why Intranasal Corticosteroids Are the Best Choice
Intranasal corticosteroids are the most effective medication class for controlling the four major nasal symptoms: sneezing, itching, rhinorrhea, and nasal congestion 1. The guidelines strongly recommend intranasal corticosteroids for treatment of rhinitis in adults, placing high value on their efficacy and low value on their rare adverse effects 2.
Post-COVID Context
While specific evidence for post-COVID nasal congestion shows mixed results for olfactory dysfunction 3, 4, intranasal corticosteroids remain the standard treatment for nasal symptoms in patients with SARS-CoV-2 infection 5. Importantly, baseline use of intranasal corticosteroids has been associated with better COVID-19 outcomes, including lower hospitalization rates 6.
Specific Recommendations
Which Spray to Use
- Mometasone furoate: 2 puffs (100 μg) once daily in each nostril 3, 4
- Fluticasone propionate: Standard dosing per product labeling
- Budesonide: Standard dosing per product labeling
All available intranasal corticosteroids show similar clinical effectiveness regardless of differences in topical potency or lipid solubility 1. Choose based on availability and patient preference.
How to Use
- Direct sprays away from the nasal septum to minimize local irritation and bleeding 1
- Onset of action typically occurs within 12 hours, though full benefit may take several days 1
- Continue for at least 2-4 weeks, as evidence suggests benefit increases with duration beyond 2 weeks 3
Safety Considerations for This 75-Year-Old Patient
Intranasal corticosteroids at recommended doses are not associated with clinically significant systemic side effects 1. Local side effects are minimal when properly used:
- Monitor the nasal septum periodically for mucosal erosions, though septal perforation is rare 1
- Nasal irritation and minor bleeding may occur but are uncommon with proper technique
- No dose adjustment needed for age
What NOT to Use
Avoid Topical Decongestants
Do not use intranasal decongestants (like oxymetazoline) for more than 3 days due to risk of rhinitis medicamentosa (rebound congestion) 1. While they can provide short-term relief for acute viral infections 1, the variability in developing rebound congestion (some patients in 3 days, others after 4-6 weeks) makes them inappropriate for residual post-COVID symptoms 1, 7.
Oral Decongestants Require Caution
Oral decongestants (pseudoephedrine, phenylephrine) can cause insomnia, irritability, and palpitations 1. In a 75-year-old, monitor for blood pressure elevation and consider cardiac comorbidities before use 1.
Oral Antihistamines Are Less Effective
Oral antihistamines are less effective than intranasal corticosteroids for nasal congestion 2, 1. They may help if allergic rhinitis is suspected, but post-viral nasal congestion typically responds better to intranasal corticosteroids.
Clinical Pitfalls to Avoid
Don't wait for symptoms to worsen: Intranasal corticosteroids can be used as initial treatment without trying antihistamines or decongestants first 1
Don't use systemic corticosteroids: A short course of oral steroids is only appropriate for very severe or intractable rhinitis, not for mild residual symptoms 1
Don't stop too early: Continue treatment for at least 2-4 weeks to assess full benefit 3
Ensure proper technique: Poor spray technique reduces efficacy and increases side effects